Latest NewsOct 30, 2025HiFiBiO Therapeutics Announces the Appointment of Leading I&I Experts to its Scientific Advisory BoardAll Filter By: Year20252024202320222021202020192018201720162015Nov 1, 2021HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200301Sep 23, 2021HiFiBiO Therapeutics Contributes to CoVIC-Led Science Publication on SARS-CoV-2 Spike Antibodies Effective Against Variants of ConcernJun 17, 2021FibroGen and HiFiBiO Announce Transformative Partnership to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune DiseaseJun 14, 2021HiFiBiO Therapeutics Closes $75 Million Series D Financing to Accelerate Pipeline with Two Lead Immuno-Oncology Programs and Validate its DIS® Approach in the ClinicJun 11, 2021HiFiBiO Therapeutics Announces Publication in Science Advances of its High-Throughput Functional Screening for Next-Generation Cancer Immunotherapy< 1 … 6 7 8 9 10 … 18 >
